Saregama invests in Bhansali Productions for strategic partnership

Marquee Jv AnnouncedStrategic Transactions View source PDF Explain this filing

SAREGAMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.7%Reaction day

₹379.50

prior close

₹384.50

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.7%-6.0% vs market

Media & Entertainment peers, median of 11sector-1.6%-5.2% vs sector

On the reaction day the stock moved 6.0 pts less than Nifty Smallcap 250 and 5.2 pts less than its Media & Entertainment peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.0

10m

-1.8

15m

-2.2

30m

-2.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.7-0.7-6.0-1.6-5.2

Next day

-7.7-0.8-6.8-2.5-5.2

-8.1+0.5-8.6-1.5-6.7

-8.6+1.5-10.0+0.0-8.6

-8.6+1.9-10.5-0.9-7.7

-7.9+1.9-9.9-1.7-6.2

-4.9+1.2-6.1+0.0-4.9

15d

-3.2+1.0-4.2-0.4-2.8

-9.1-1.9-7.3-6.3-2.9

-9.4-1.4-8.0-6.9-2.4

-7.5-8.8+1.4-13.8+6.4

UpDownMarket · Nifty Smallcap 250Sector · Media & Entertainment peers, median of 11Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Saregama is making a significant equity investment in Bhansali Productions. Bhansali will exclusively sell future film music to Saregama on a pre-agreed formula, guaranteeing long-term market share. Bhansali FY25: revenue Rs 304 crore, EBITDA Rs 60 crore, PAT Rs 45 crore, with over 10 films planned. Saregama will phase out in-house film production over 1-2 years. Deal expected to be EPS accretive by FY27.

Likely market impact

Strategic stake in marquee filmmaker secures premium music pipeline and expected EPS accretion by FY27, positive for shareholders.